Skip to main content
. 2021 Sep 10;13(18):4550. doi: 10.3390/cancers13184550

Figure 2.

Figure 2

Tumor bulk and CSC-based combined treatments of HCC. Top panel: tumor bulk-directed treatments might lead to tumor relapse due to CSC reactivation. Central panel: CSC-directed treatments might lead to tumor relapse due to the acquisition of further DNA mutations and the possible transdifferentiation of tumor cells. Bottom panel: increased efficacy of combined treatments leading to tumor eradication.